COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- An overview on the nutrition transition and its health implications: Tunisia case
- Nutrition in contemporary Zimbabwe: a situational analysis
- Pre-exposure and Post-exposure new prophylactic treatments against COVID-19 in healthcare workers
- Seed from olive cake prevents hyperglycemia, hyperlipidemia, and oxidative stress in dexamethasone-induced diabetes rats
- Effects of Beetroot and Pomegranate Juice Supplementation on Creatine Kinase and C-Reactive Protein in Amateur Soccer Players
- The Inhibitory Effect of Selenium Supplementation on Tumor Progression in a DMBA-Induced Breast Cancer Model in Wistar Rats
- Effects of the Withania somnifera supplementation on sports performance: a systematic review and meta-analysis
- Differences in dietary intake between Turkish vegans and omnivores: a cross-sectional study
- Effects of fermentation period and soybean flour supplementation on the glycemic indices and starch digestibility of biofortified provitamin A cassava meal
- Nutritional status and nutrient adequacy of food consumed by non-academic staff in a Nigerian university
You may also start an advanced similarity search for this article.
NAJFNR is licensed under